AUAUniversity Podcast Series: Episode No. 69
GU Podcast (2020): Advanced Prostate Cancer - AUA ASTRO SUO Guideline Podcast Part 1
At the conclusion of this activity, participants will be able to:
- Analyze breakthrough treatments in the management of advanced and metastatic hormone sensitive prostate cancer (mHSPC) and castration resistant prostate cancer (CRPC).
- Identify the active agents and their mechanism of action in the management of mHSPC, nmCRPC and mCRPC.
- Describe the indications, sequencing and combinations for treatment with approved agents in the management of mHSPC and nmCRPC.
This educational series is supported by independent educational grants from:
Bristol Myers Squibb
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
UroGen Pharma, Inc.